Hims halts copycat Wegovy pill

Kim Kahn reports Hims & Hers stopping its compounded semaglutide access after industry and FDA pressure.

Play episode from 02:25

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!